1
|
Sun X, Xie Y, Qu J, Yuan D. Systematic characterization of components of Makyo-kanseki-to granule and serum metabolomics for exploring its protective mechanism against acute lung injury in lipopolysaccharide-induced rats. J Sep Sci 2023; 46:e2200705. [PMID: 36385590 DOI: 10.1002/jssc.202200705] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2022] [Revised: 11/06/2022] [Accepted: 11/07/2022] [Indexed: 11/19/2022]
Abstract
Makyo-kanseki-to has been used for the treatment of pneumonia, becoming a basic formula for coronavirus disease 2019. However, the chemical profile of Makyo-kanseki-to granule and its possible mechanism against acute lung injury from terminal metabolic regulation have been unclear. The aim of this study was to characterize the constituents in Makyo-kanseki-to granule and reveal the potential related mechanism of Makyo-kanseki-to granule treatment for acute lung injury using a rat model of lipopolysaccharide-induced acute lung injury. Totally, 78 constituents were characterized based on ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. Makyo-kanseki-to granule could alleviate acute lung injury through modulating rectal temperature, pulmonary edema, histopathology, and processes of inflammatory and oxidative stress. Twenty-two potential biomarkers in acute lung injury rats were identified by metabolomics based on ultra-performance liquid chromatography coupled with quadrupole exactive high-field mass spectrometry. They were mainly involved in amino acids and glycerophospholipid metabolism, which were regulated by Makyo-kanseki-to granule. The present results not only increase the understanding of the chemical profile and molecular mechanism of Makyo-kanseki-to granule mediated protection against acute lung injury but also provide an experimental basis and new ideas for further development and clinical application of Makyo-kanseki-to granule.
Collapse
Affiliation(s)
- Xin Sun
- Department of Traditional Chinese Medicine, Shenyang Pharmaceutical University, Shenyang, P. R. China
| | - Yuanyuan Xie
- Key Laboratory of Digitalized Quality Evaluation Technology of Traditional Chinese Medicine, State Administration of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, P. R. China
| | - Jialing Qu
- Clinical Laboratory of Integrative Medicine, The first affiliated hospital of Dalian Medical University, Dalian, P. R. China
| | - Dan Yuan
- Department of Traditional Chinese Medicine, Shenyang Pharmaceutical University, Shenyang, P. R. China
| |
Collapse
|
2
|
Ren Z, Zhang H, Wang Z, Chen X, Yang L, Jiang H. Progress in Immunoassays of Toxic Alkaloids in Plant-Derived Medicines: A Review. Toxins (Basel) 2022; 14:toxins14030165. [PMID: 35324662 PMCID: PMC8948709 DOI: 10.3390/toxins14030165] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2022] [Revised: 02/14/2022] [Accepted: 02/21/2022] [Indexed: 02/04/2023] Open
Abstract
Plants are the cradle of the traditional medicine system, assuaging human or animal diseases, and promoting health for thousands of years. However, many plant-derived medicines contain toxic alkaloids of varying degrees of toxicity that pose a direct or indirect threat to human and animal health through accidental ingestion, misuse of plant materials, or through the food chain. Thus, rapid, easy, and sensitive methods are needed to effectively screen these toxic alkaloids to guarantee the safety of plant-derived medicines. Antibodies, due to their inherent specificity and high affinity, have been used as a variety of analytical tools and techniques. This review describes the antigen synthesis and antibody preparation of the common toxic alkaloids in plant-derived medicines and discusses the advances of antibody-based immunoassays in the screening and detection of toxic alkaloids in plants or other related matrices. Finally, the limitations and prospects of immunoassays for toxic alkaloids are discussed.
Collapse
|
3
|
Guo T, Guo Y, Liu Q, Xu Y, Wei L, Wang Z, Chen S, Wang C, Tian Y, Cui J, Wang Y, Wang Y, Sun L. The TCM prescription Ma-xing-shi-gan-tang inhibits Streptococcus pneumoniae pathogenesis by targeting pneumolysin. JOURNAL OF ETHNOPHARMACOLOGY 2021; 275:114133. [PMID: 33892068 DOI: 10.1016/j.jep.2021.114133] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/21/2021] [Revised: 04/16/2021] [Accepted: 04/17/2021] [Indexed: 06/12/2023]
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE Ma-xing-shi-gan-tang (MXSGT), which is documented in the Treatise on Febrile Diseases and is a therapeutic drug, is a well-known classic prescription in China and has been widely studied. Previous studies have shown that MXSGT has various pharmacological activities, including anti-influenza virus activity, and ameliorates microvascular hyperpermeability and inflammatory reactions. However, no study has reported the effect of MXSGT in the treatment of bacterial pneumonia. AIM OF THE STUDY In this study, the potential inhibition of MXSGT against the virulence of S. pneumoniae by targeting PLY was investigated. MATERIALS AND METHODS First, HPLC analysis was used to determine the main components of MXSGT. Then PLY protein was constructed and used for hemolysis assay and western blot to test the ability of MXSGT to inhibit PLY activity, production and widowed characteristics. The growth curve of S. pneumoniae was drawled with or without MXSGT treatment. In addition, the inhibition of MXSGT against PLY-mediated A549 cell death was examined by cytotoxicity assay. Finally, the mouse experiment was used to verify the effect of MXSGT on mouse lungs. RESULTS This work has discovered that MXSGT, a TCM prescription, is an effective inhibitor of PLY, an important virulence factor that is essential for S. pneumoniae pathogenicity. MXSGT inhibits the oligomerization of PLY without affecting S. pneumoniae growth and PLY production. In addition, experimental MXSGT treatment was effective against S. pneumoniae infection both in vitro and in vivo. CONCLUSION These findings directly demonstrate the potential mechanism of the Chinese herbal formula MXSGT in the treatment of pneumococcal disease and provide additional evidence for promotion of the wide use of MXSGT in the clinic.
Collapse
Affiliation(s)
- Tingting Guo
- Changchun University of Chinese Medicine, Changchun, Jilin, 130117, China
| | - Yinan Guo
- Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin, 130021, China
| | - Qingbing Liu
- Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin, 130021, China
| | - Yan Xu
- Changchun University of Chinese Medicine, Changchun, Jilin, 130117, China
| | - Lina Wei
- Changchun University of Chinese Medicine, Changchun, Jilin, 130117, China
| | - Zhongtian Wang
- Changchun University of Chinese Medicine, Changchun, Jilin, 130117, China
| | - Si Chen
- Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin, 130021, China
| | - Caiwen Wang
- Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin, 130021, China
| | - Ye Tian
- Changchun University of Chinese Medicine, Changchun, Jilin, 130117, China
| | - Jie Cui
- Changchun University of Chinese Medicine, Changchun, Jilin, 130117, China
| | - Yijie Wang
- Changchun University of Chinese Medicine, Changchun, Jilin, 130117, China
| | - Yanbo Wang
- Changchun University of Chinese Medicine, Changchun, Jilin, 130117, China.
| | - Liping Sun
- Changchun University of Chinese Medicine, Changchun, Jilin, 130117, China.
| |
Collapse
|
4
|
Gowthaman V, Kumar S, Koul M, Dave U, Murthy TRGK, Munuswamy P, Tiwari R, Karthik K, Dhama K, Michalak I, Joshi SK. Infectious laryngotracheitis: Etiology, epidemiology, pathobiology, and advances in diagnosis and control - a comprehensive review. Vet Q 2021; 40:140-161. [PMID: 32315579 PMCID: PMC7241549 DOI: 10.1080/01652176.2020.1759845] [Citation(s) in RCA: 19] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
Infectious laryngotracheitis (ILT) is a highly contagious upper respiratory tract disease of chicken caused by a Gallid herpesvirus 1 (GaHV-1) belonging to the genus Iltovirus, and subfamily Alphaherpesvirinae within Herpesviridae family. The disease is characterized by conjunctivitis, sinusitis, oculo-nasal discharge, respiratory distress, bloody mucus, swollen orbital sinuses, high morbidity, considerable mortality and decreased egg production. It is well established in highly dense poultry producing areas of the world due to characteristic latency and carrier status of the virus. Co-infections with other respiratory pathogens and environmental factors adversely affect the respiratory system and prolong the course of the disease. Latently infected chickens are the primary source of ILT virus (ILTV) outbreaks irrespective of vaccination. Apart from conventional diagnostic methods including isolation and identification of ILTV, serological detection, advanced biotechnological tools such as PCR, quantitative real-time PCR, next generation sequencing, and others are being used in accurate diagnosis and epidemiological studies of ILTV. Vaccination is followed with the use of conventional vaccines including modified live attenuated ILTV vaccines, and advanced recombinant vector vaccines expressing different ILTV glycoproteins, but still these candidates frequently fail to reduce challenge virus shedding. Some herbal components have proved to be beneficial in reducing the severity of the clinical disease. The present review discusses ILT with respect to its current status, virus characteristics, epidemiology, transmission, pathobiology, and advances in diagnosis, vaccination and control strategies to counter this important disease of poultry.
Collapse
Affiliation(s)
- Vasudevan Gowthaman
- Poultry Disease Diagnosis and Surveillance Laboratory, Tamil Nadu Veterinary and Animal Sciences University, Namakkal, Tamil Nadu, India
| | - Sachin Kumar
- Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam, India
| | - Monika Koul
- Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam, India
| | - Urmil Dave
- Department of Biosciences and Bioengineering, Indian Institute of Technology Guwahati, Guwahati, Assam, India
| | - T R Gopala Krishna Murthy
- Poultry Disease Diagnosis and Surveillance Laboratory, Tamil Nadu Veterinary and Animal Sciences University, Namakkal, Tamil Nadu, India
| | - Palanivelu Munuswamy
- Division of Pathology, ICAR - Indian Veterinary Research Institute, Izatnagar, Uttar Pradesh, India
| | - Ruchi Tiwari
- Department of Veterinary Microbiology and Immunology, College of Veterinary Sciences, UP Pandit Deen Dayal Upadhayay Pashu Chikitsa Vigyan Vishwavidyalay Evum Go-Anusandhan Sansthan (DUVASU), Mathura, Uttar Pradesh, India
| | - Kumaragurubaran Karthik
- Central University Laboratory, Tamil Nadu Veterinary and Animal Sciences University, Chennai, Tamil Nadu, India
| | - Kuldeep Dhama
- Division of Pathology, ICAR - Indian Veterinary Research Institute, Izatnagar, Uttar Pradesh, India
| | - Izabela Michalak
- Faculty of Chemistry, Department of Advanced Material Technologies, Wrocław University of Science and Technology, Wrocław, Poland
| | - Sunil K Joshi
- Department of Microbiology & Immunology, Department of Pediatrics, Division of Hematology, Oncology and Bone Marrow Transplantation, University of Miami School of Medicine, Miami, Florida, USA
| |
Collapse
|
5
|
Wei L, Guo Y, Fei Y, Luo L, Wang C, Wang X, Sun H, Liu L, Han J, Ren X, Yao B, Wang L, Wang Y, Sun L. A randomized, double-blind, placebo-controlled, multicenter clinical trial for efficacy and safety of traditional Chinese medicine combined with antibiotics in the treatment of bacterial pneumonia in children. Medicine (Baltimore) 2020; 99:e23217. [PMID: 33327240 PMCID: PMC7738059 DOI: 10.1097/md.0000000000023217] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022] Open
Abstract
BACKGROUND Pneumonia is the second leading cause of death in children worldwide after preterm birth and certification. Bacteria, viruses, mycoplasma, and other microorganisms are known to be the main causes of pneumonia, of which bacterial pathogenic factors account for 12.5% of cases. The invention and application of antibiotics have improved the prognosis of children with community-acquired bacterial pneumonia (CABP) to a certain extent, but with the emergence of antibiotic resistance worldwide, the mortality of children with CABP is still high. "Maxing Shigan Decoction" and "Qingfei Decoction" have significant efficacy in the treatment of CABP in children, but there is no standardized randomized controlled trial to systematically evaluate the outcomes. METHODS This study is a randomized, double-blind, placebo-controlled, multicenter clinical trial that will randomize 240 patients with CABP to group of Oral Maxing Shigan Decoction, group of Qingfei Decoction or group of placebos administered 3 times a day for 7 days. This study will observe a wide range of clinically relevant endpoints that have been used in clinical trials of pneumonia, including but not limited to clinical cure rate, antibiotic application days, complete antipyretic rate, complete antipyretic days, disease efficacy, traditional Chinese medicine syndrome effect, and antibiotic upgrade treatment rates. Safety will be assessed by monitoring for the incidence of adverse events during the study. DISCUSSION This clinical trial is the first to evaluate the efficacy and safety of "Maxing Shigan Decoction" and "Qingfei Decoction" in the treatment of children with CABP. The research results will provide a reference for future research design. TRIAL REGISTRATION Chinese Clinical Trial Registry, ChiCTR1900025354. Registered on 14th October 2019-Retrospectively registered, http://www.chictr.org.cn/.
Collapse
Affiliation(s)
- Lina Wei
- First Affiliated Hospital to Changchun University of Chinese Medicine, Jilin
| | - Yina Guo
- First Affiliated Hospital to Changchun University of Chinese Medicine, Jilin
| | | | - Lin Luo
- Research Institute of China Academy of Chinese Medical Sciences, Beijing, China
| | - Caiwen Wang
- First Affiliated Hospital to Changchun University of Chinese Medicine, Jilin
| | - Xuejiao Wang
- First Affiliated Hospital to Changchun University of Chinese Medicine, Jilin
| | - Haihang Sun
- Changchun University of Chinese Medicine, Changchun
| | - Liang Liu
- Changchun University of Chinese Medicine, Changchun
| | - Jing Han
- Changchun University of Chinese Medicine, Changchun
| | - Xiaoting Ren
- Changchun University of Chinese Medicine, Changchun
| | - Bo Yao
- Changchun University of Chinese Medicine, Changchun
| | - Lei Wang
- Changchun University of Chinese Medicine, Changchun
| | - Yijie Wang
- Changchun University of Chinese Medicine, Changchun
| | - Liping Sun
- Changchun University of Chinese Medicine, Changchun
| |
Collapse
|
6
|
Du Z, Risu N, Gentu G, Jia Y, Cai Y. Growth performance, apparent digestibility, and N balance in Mongolian lambs and hoggs fed diets supplemented with a Chinese traditional herbal medicine complex. Anim Sci J 2018; 89:1451-1458. [DOI: 10.1111/asj.13081] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2018] [Accepted: 06/15/2018] [Indexed: 12/28/2022]
Affiliation(s)
- Zhumei Du
- Key Laboratory of Forage Cultivation, Processing and High Efficient Utilization of Ministry of Agriculture; Key Laboratory of Grassland Resources; Ministry of Education; College of Grassland, Resources and Environment; Inner Mongolia Agricultural University; Hohhot Inner Mongolia China
| | - Na Risu
- The center of Ecology and Agrimeteorology of Inner Mongolia; Hohhot Inner Mongolia China
| | - Ge Gentu
- Key Laboratory of Forage Cultivation, Processing and High Efficient Utilization of Ministry of Agriculture; Key Laboratory of Grassland Resources; Ministry of Education; College of Grassland, Resources and Environment; Inner Mongolia Agricultural University; Hohhot Inner Mongolia China
| | - Yushan Jia
- Key Laboratory of Forage Cultivation, Processing and High Efficient Utilization of Ministry of Agriculture; Key Laboratory of Grassland Resources; Ministry of Education; College of Grassland, Resources and Environment; Inner Mongolia Agricultural University; Hohhot Inner Mongolia China
| | - Yimin Cai
- Japan International Research Center for Agricultural Sciences (JIRCAS); Tsukuba Ibaraki Japan
| |
Collapse
|
7
|
Shen P, Shen J, Sun C, Yang X, He L. A system biology approach to understanding the molecular mechanisms of Gubentongluo decoction acting on IgA Nephropathy. Altern Ther Health Med 2016; 16:312. [PMID: 27558012 PMCID: PMC4997663 DOI: 10.1186/s12906-016-1268-9] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/30/2015] [Accepted: 08/02/2016] [Indexed: 11/16/2022]
Abstract
Background Traditional Chinese medicine (TCM) has been widely used in treating various diseases in eastern Asia for several thousand years, and is becoming increasingly popular in western countries. Gubentongluo (GBTL) decoction, as a classic TCM formula, is commonly applied to treat IgA Nephropathy (IgAN) in China. To date, however, the pharmacological/molecular mechanisms of GBTL have not been fully elucidated. Method In the present study, we used a system biological approach to explore these mechanisms acting on IgAN. Results First, we found 3876 potential target proteins for GBTL (based on TCMID) and 25 known IgAN associated biomarkers (based on the OMIM or IPA database).16 of the latter biomarkers were direct targets of 6 of the 9 herbs in GBTL, suggesting that these components play a vital role in treating IgAN. Second, we showed that these 6 herbs mainly regulate the immune system and renin-angiotensin system, imbalance in which is the main factor leading to IgAN. Importantly, HUANG QI links with 14 biomarkers, indicating that it is the most important herb in GBTL for treating IgAN. Also, relationships of other herbs with IgAN were explored. Third, we demonstrated that the remaining 9 IgAN associated proteins are responses to biological processes, such as antigen processing, protein ubiquitination and cell cycle regulation, which are crucial for IgAN development. Finally, we found that GBTL could induce a significant increase in the levels of two target gene: TNF and NOS2. Conclusions Further studies are called to develop/modify the formula of GBTL, in order to enhance its effect on IgAN. Electronic supplementary material The online version of this article (doi:10.1186/s12906-016-1268-9) contains supplementary material, which is available to authorized users.
Collapse
|
8
|
Xi N, Kang J, Hao L, Li R, Bao Y, Shi W. Effects Of Ultrafine Powder of the Stem and Leaf of Astragalus on Immunity in Chickens. ITALIAN JOURNAL OF ANIMAL SCIENCE 2016. [DOI: 10.4081/ijas.2014.3022] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/11/2023]
|